Key result
AST/ALT ratio ≥1 is linked to ~9-point lower LVEF in alcohol-induced cardiomyopathy.
Why the study?
The AST/ALT ratio may reflect systemic tissue injury and impaired cardiovascular function, but evidence regarding its relationship with the severity of alcohol-induced cardiomyopathy remains limited.
Does an AST/ALT ratio ≥1 correlate with severe systolic dysfunction and advanced NYHA functional class in adult patients with chronic heavy alcohol consumption and alcohol-induced cardiomyopathy?
Cross-Sectional (n=100)
No
Does an AST/ALT ratio ≥1 correlate with severe systolic dysfunction and advanced NYHA functional class in adult patients with chronic heavy alcohol consumption and alcohol-induced cardiomyopathy?
An elevated AST/ALT ratio (≥1) is independently associated with reduced left ventricular ejection fraction and advanced NYHA functional class in patients with alcohol-induced cardiomyopathy, suggesting its utility as a simple adjunctive marker for disease severity.
Answers are grounded in this paper and cite their sources.
May flag reduced LVEF; leaves open whether ratio extends to prognosis or management.
Background: Alcohol-induced cardiomyopathy (ACM) is an acquired form of dilated cardiomyopathy resulting from prolonged heavy alcohol consumption. Chronic ethanol exposure produces myocardial oxidative stress, mitochondrial dysfunction, myocyte injury, ventricular remodeling and progressive systolic dysfunction. The aspartate aminotransferase/alanine aminotransferase (AST/ALT) ratio, also known as the De Ritis ratio, is traditionally used as a marker of hepatocellular injury but may also reflect systemic tissue injury and impaired cardiovascular function. Evidence regarding its relationship with severity of alcohol-induced cardiomyopathy remains limited. Materials and Methods: A cross-sectional observational study was conducted in the Department of Medicine at a tertiary care hospital. One hundred adult patients with chronic heavy alcohol consumption and echocardiographically documented alcohol-induced cardiomyopathy were included. Serum AST and ALT were measured and the AST/ALT ratio was calculated. Patients were categorized into two groups according to an AST/ALT ratio <1 or ≥1. Echocardiography was performed to assess left ventricular ejection fraction (LVEF), LV dimensions and associated structural abnormalities. For this cross-sectional analysis, poorer cardiac prognosis was operationalized by severe systolic dysfunction and advanced NYHA functional class. Results:Of the 100 patients, 35 had an AST/ALT ratio <1 and 65 had a ratio ≥1. Patients with a ratio ≥1 demonstrated lower mean LVEF than those with a ratio <1 (34.7 ± 7.8% vs. 43.8 ± 8.6%, p<0.001) and had a greater frequency of NYHA class III–IV symptoms (49.2% vs. 14.3%, p<0.001). Advanced ventricular dilation, atrial enlargement and clinically significant arrhythmias were also more frequent in the higher-ratio group. The AST/ALT ratio demonstrated an inverse correlation with LVEF (r=-0.52, p<0.001). On multivariable analysis, AST/ALT ratio ≥1 was independently associated with severe cardiac dysfunction after adjustment for age, duration of alcohol exposure, hypertension and serum albumin.Conclusion: An elevated AST/ALT ratio was associated with poorer cardiac functional status, reduced LVEF and advanced NYHA class among chronic alcoholic patients with alcohol-induced cardiomyopathy. The ratio is inexpensive and routinely available and may serve as an adjunctive marker for identifying patients requiring more intensive cardiovascular assessment. Prospective longitudinal studies are required to determine whether it independently predicts hospitalization or mortality.
No takes yet. Share an insight, caveat, or question.
Dr. Akash Naik R1, Dr. Sowmyashree S N2, Dr. Prajwal Naik R3 (2026) conducted a cross-sectional in Alcohol-induced cardiomyopathy (n=100). AST/ALT ratio ≥1 vs. AST/ALT ratio <1 was evaluated on Mean left ventricular ejection fraction (LVEF) and NYHA class III–IV symptoms (r=-0.52, p=<0.001). An AST/ALT ratio ≥1 was associated with lower LVEF (34.7% vs 43.8%, p<0.001) and higher NYHA III–IV rates (49.2% vs 14.3%, p<0.001) vs a ratio <1 in alcohol-induced cardiomyopathy.
Synapse has enriched 10 related papers. Consider them for comparative context: